Show simple item record

Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].

dc.contributor.authorSafaei, S
dc.contributor.authorBaradaran, B
dc.contributor.authorHagh, MF
dc.contributor.authorAlivand, MR
dc.contributor.authorTalebi, M
dc.contributor.authorGharibi, T
dc.contributor.authorSolali, S
dc.date.accessioned2018-08-26T04:53:53Z
dc.date.available2018-08-26T04:53:53Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38020
dc.language.isoEnglish
dc.relation.ispartofBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
dc.titleCorrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
dc.typearticle
dc.citation.volume101
dc.citation.spage786
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.biopha.2018.02.101


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record